Brian Pereira J.G.'s most recent trade in ProKidney Corp - Ordinary Shares - Class A was a trade of 447,803 Class A Common Stock done at an average price of $2.4 . Disclosure was reported to the exchange on Nov. 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ProKidney Corp Ordinary | Brian J.G. Pereira | Director | Sale of securities on an exchange or to another person at price $ 2.37 per share. | 12 Nov 2025 | 447,803 | 0 | - | 2.4 | 1,061,293 | Class A Common Stock |
| ProKidney Corp Ordinary | Brian J.G. Pereira | Director | Sale of securities on an exchange or to another person at price $ 2.72 per share. | 12 Nov 2025 | 227,431 | 447,803 | - | 2.7 | 619,363 | Class A Common Stock |
| ProKidney Corp Ordinary | Brian J.G. Pereira | Director | Sale of securities on an exchange or to another person at price $ 2.37 per share. | 12 Nov 2025 | 54,333 | 0 | - | 2.4 | 128,769 | Class A Common Stock |
| ProKidney Corp Ordinary | Brian J.G. Pereira | Director | Sale of securities on an exchange or to another person at price $ 2.72 per share. | 12 Nov 2025 | 27,595 | 54,333 | - | 2.7 | 75,152 | Class A Common Stock |
| KalVista Pharma Inc | Brian Pereira J.G. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| ProKidney Corp Ordinary | Brian J.G. Pereira | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 125,862 | 125,862 | - | - | Director stock option (right to buy) | |
| ProKidney Corp Ordinary | Brian J.G. Pereira | Director | 04 Feb 2025 | 675,234 | 675,234 | - | 0 | Class A Ordinary Shares | ||
| ProKidney Corp Ordinary | Brian J.G. Pereira | Director | 04 Feb 2025 | 675,234 | 675,235 | - | - | Class B Ordinary Shares | ||
| ProKidney Corp Ordinary | Brian J.G. Pereira | Director | 04 Feb 2025 | 675,234 | 675,235 | - | - | Common Units in ProKidney LP | ||
| ProKidney Corp Ordinary | Brian J.G. Pereira | Director | 04 Feb 2025 | 81,928 | 81,928 | - | 0 | Class A Ordinary Shares | ||
| ProKidney Corp Ordinary | Brian J.G. Pereira | Director | 04 Feb 2025 | 81,928 | 81,929 | - | - | Class B Ordinary Shares | ||
| ProKidney Corp Ordinary | Brian J.G. Pereira | Director | 04 Feb 2025 | 81,928 | 81,929 | - | - | Common Units in ProKidney LP | ||
| KalVista Pharma Inc | Brian J.G. Pereira | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| ProKidney Corp Ordinary | Brian J.G. Pereira | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 62,558 | 62,558 | - | - | Director stock option (right to buy) | |
| ProKidney Corp Ordinary | Brian J.G. Pereira | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2023 | 48,128 | 48,128 | - | - | Director stock option (right to buy) | |
| KalVista Pharma Inc | Brian J.G. Pereira | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2022 | 10,000 | 10,000 | - | - | Employee Stock Option (right to buy) | |
| ProKidney Corp Ordinary | Brian J.G. Pereira | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 1,514,326 | 1,514,326 | - | - | Class B Ordinary Shares | |
| ProKidney Corp Ordinary | Brian J.G. Pereira | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 1,514,326 | 1,514,326 | - | - | Common Units in ProKidney LP | |
| KalVista Pharma Inc | Brian J.G. Pereira | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 10,000 | 10,000 | - | - | Director Stock Option (Right to Buy) |